GAD THOMAS (President and Chairman) sold 5.1% of their position (10.81K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $56.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2025ACC: 0001415889-25-007737
DirectorOfficer· President and Chairman
Since Sep 2018
-10.81K
Net shares
Net seller
$56.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.81K
Price / share
$5.23
Trade value
$56.54K
% of position
5.1%
3/7/2025
213.53K→202.72K
Total
Net shares
−10.81K
Net value
-$56.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2025 | S · Sale | −10.81K | $5.23 | $56.54K | 5.1% | 213.53K | 202.72K |
| Total | −10.81K | -$56.54K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned60K
Common Stock
IndirectShares owned67.68K
Total
127.68K indirect127.68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60K | Indirect |
| Common Stock | 67.68K | Indirect |
| Total | 127.68K | 127.68K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported